BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 2
• 3
• 4
• 5
• 7
• 8
• 9
• 10

• Press Releases

  Novartis IgAN data in The Lancet show clinically meaningful slowing of kidney function decline with Vanrafia® over 2.5 years

  June 4, 2026

   · 

  11 min read
• Press Releases

  Muna Therapeutics Announces Nature Medicine Publication Validating Microglial State Transitions as Key Drivers of Alzheimer’s

  June 4, 2026

   · 

  3 min read
• Press Releases

  Biolog Expands Service Lab Footprint and Eliminates Barriers Between Clients and Microbial Insights

  June 4, 2026

   · 

  2 min read
• Press Releases

  Reply and IEO Launch Collaboration to Co-Develop and Train Domain-Specific Large Language Models for Oncology

  June 4, 2026

   · 

  3 min read
• Press Releases

  CeQur® Announces Exciting Advancements: 2 Recent FDA Clearances and New Clinical Evidence to be Presented at ADA

  June 4, 2026

   · 

  3 min read
• Press Releases

  CereVasc, Inc. Announces Over-Subscribed $85 Million Series C Financing to Advance its Novel eShunt® System for the Treatment of Normal Pressure Hydrocephalus

  June 4, 2026

   · 

  4 min read
• Press Releases

  Fractyl Health Reports Positive One-Year REVEAL-1 Open-Label Results Showing Sustained Post-GLP-1 Weight Maintenance After a Single Revita® Procedure

  June 4, 2026

   · 

  9 min read
• Press Releases

  AEON Biopharma to Present Data Demonstrating Structural and Functional Comparability of ABP-450 to BOTOX® at the 68th Annual Scientific Meeting of the American Headache Society

  June 4, 2026

   · 

  4 min read
• Press Releases

  Axsome Therapeutics Presents New SYMBRAVO® Data at the Americal Headache Society (AHS) 68th Annual Scientific Meeting

  June 4, 2026

   · 

  5 min read
• Press Releases

  Attralus Therapeutic Zamubafusp Alfa (AT-02) Receives U.S. FDA Orphan Drug Designation for the Treatment of AL Amyloidosis

  June 4, 2026

   · 

  4 min read